Lazard Capital Starts Ventrus Biosciences (VTUS) at Buy
Tweet Send to a FriendGet Alerts VTUS Hot Sheet
Price: $2.76 --0%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 3 | New: 3
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 3 | New: 3
Trade VTUS Now!
Lazard Capital initiates coverage on Ventrus Biosciences (NASDAQ: VTUS) with a Buy. PT $24.00.
For more ratings news on Ventrus Biosciences click here and for the rating history of Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $11.89 yesterday, with a 52 week range of $5.75-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Ventrus Biosciences click here and for the rating history of Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $11.89 yesterday, with a 52 week range of $5.75-$21.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
- Global Hunter Securities Starts New Gold (NGD) at Buy
- SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Ventrus Biosciences, Inc. and Certain Officers -- VTUS
Create E-mail Alert Related Categories
New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
